Evidence map›Paper›PMID 22363548›Full record

ArticlePloS one2012

Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch.

Xiaoxia Z West, Nahum Meller, Nikolay L Malinin, Lalit Deshmukh, Julia Meller, Ganapati H Mahabeleshwar, Malory E Weber, Bethany A Kerr, Olga Vinogradova, Tatiana V Byzova

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Recombinant RGD-disintegrin DisBa-01 blocks integrin αCell communication and signaling : CCS · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Mechanisms and regulation of endothelial VEGF receptor signalling.Nature reviews. Molecular cell biology · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.American journal of physiology. Heart and circulatory physiology · 2013
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Xiaoxia Z WestDepartment of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
Nahum Meller
Nikolay L Malinin
Lalit Deshmukh
Julia Meller
Ganapati H Mahabeleshwar
Malory E Weber
Bethany A Kerr
Olga Vinogradova
Tatiana V Byzova
Cleveland Clinic Lerner College of Medicine · USCase Western Reserve University · USNational Institutes of Health · USUniversity of Connecticut · US

Funding

Investigation of the VEGFR/Integrin cytoplasmic domains interaction.R21HL098777 · NHLBI · UNIVERSITY OF CONNECTICUT STORRS · PI VINOGRADOVA, OLGA · 2010 to 2011
$421k
NHLBI NIH HHS R21 HL098777
6 · The paper itself

Abstract

Integrins mediate cell adhesion, migration, and survival by connecting intracellular machinery with the surrounding extracellular matrix. Previous studies demonstrated the importance of the interaction between β(3) integrin and VEGF type 2 receptor (VEGFR2) in VEGF-induced angiogenesis. Here we present in vitro evidence of the direct association between the cytoplasmic tails (CTs) of β(3) and VEGFR2. Specifically, the membrane-proximal motif around (801)YLSI in VEGFR2 mediates its binding to non-phosphorylated β(3)CT, accommodating an α-helical turn in integrin bound conformation. We also show that Y(747) phosphorylation of β(3) enhances the above interaction. To demonstrate the importance of β(3) phosphorylation in endothelial cell functions, we synthesized β(3)CT-mimicking Y(747) phosphorylated and unphosphorylated membrane permeable peptides. We show that a peptide containing phospho-Y(747) but not F(747) significantly inhibits VEGF-induced signaling and angiogenesis. Moreover, phospho-Y(747) peptide exhibits inhibitory effect only in WT but not in β(3) integrin knock-out or β(3) integrin knock-in cells expressing β(3) with two tyrosines substituted for phenylalanines, demonstrating its specificity. Importantly, these peptides have no effect on fibroblast growth factor receptor signaling. Collectively these data provide novel mechanistic insights into phosphorylation dependent cross-talk between integrin and VEGFR2.

Indexed as

Receptor Cross-TalkAmino Acid MotifsAmino Acid SequenceAnimalsEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHumansHuman Umbilical Vein Endothelial CellsIntegrin beta3In Vitro TechniquesMagnetic Resonance SpectroscopyMiceMice, Inbred C57BLMolecular Sequence DataNeovascularization, PhysiologicPeptidesExtracellular Signal-Regulated MAP KinasesIntegrin beta3PeptidesPhosphotyrosineVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID22363548
PMCPMC3281915
OpenAlexW2001186215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.